SUMMARY
Skincare Vitamin B1 functions as a novel immunomodulator that reprograms skin dendritic cell efferocytosis and antigen presenting cell functions, leading to enhanced skin immunity for would healing and anti-tumor purpose
The Unmet Need: Targeted therapies to bolster the skin’s natural defenses by enhancing functions of skin-resident immune cells
-
The skin serves as the body’s largest organ and a vital barrier against environmental threats, including pathogens, toxins, and physical injuries. Integral to this protective function is the skin’s immune system, which relies heavily on specialized cells such as dendritic cells to detect danger, clear damaged or dying cells, and initiate immune responses. With the increasing prevalence of chronic wounds, skin infections, and skin cancers, there is a growing need for therapies that can enhance the skin’s innate and adaptive immune functions. While topical skincare products are widely used for cosmetic and protective purposes, their ability to modulate the underlying immune mechanisms of the skin remains largely unexplored. As such, there is significant interest in developing new approaches that can directly strengthen skin immunity, improve wound healing, and provide protection against malignancies.
-
Current approaches to skin care and wound healing primarily focus on maintaining skin hydration, providing antimicrobial protection, or delivering growth factors to promote tissue repair. However, these strategies often lack a targeted mechanism to enhance the immune function of skin-resident dendritic cells, which are essential for clearing apoptotic cells and presenting antigens to initiate effective immune responses. Moreover, existing immunomodulatory treatments for skin conditions can be non-specific, potentially leading to unwanted side effects or insufficient efficacy, especially in immunocompromised or diabetic individuals. There is also a gap in mechanistic understanding of how topical agents can influence immune cell behavior at the molecular level, limiting the development of rational, evidence-based therapies that address both wound healing and anti-tumor immunity. This highlights the need for innovative solutions that can precisely reprogram skin immune cells to optimize their protective functions.
The Proposed Solution: Topical Vitamin B1 to enhance skin immunity by reprogramming dendritic cells for optimized efferocytosis and antigen presentation
-
The faculty inventor optimized use of topical Vitamin B1 (VB1) to enhance skin immunity by directly reprogramming dendritic cells, which are key players in the skin’s immune defense. When applied to the skin, VB1 is absorbed by dendritic cells and converted into its bioactive form, thiamine pyrophosphate (TPP). TPP then stabilizes a specific protein which leads to improved efferocytosis—the process by which dendritic cells clear away apoptotic (dead or dying) cells—and enhances their ability to present antigens. These changes result in more robust immune surveillance and response within the skin, leading to accelerated wound healing and stronger anti-tumor activity. Experimental studies in both mouse and human cells, as well as in animal models of diabetes and melanoma, have demonstrated that topical VB1 not only speeds up wound repair but also reduces tumor growth and improves the infiltration and activation of immune cells at sites of injury or malignancy.
-
What differentiates this technology is its mechanistic, targeted approach to enhancing skin immunity, which stands in contrast to conventional skincare products that often lack scientifically validated immunological effects. The technology’s impact is further supported by retrospective clinical data linking higher VB1 levels to better outcomes in cancer therapies, suggesting broader systemic benefits. Its novelty lies in repurposing a well-known vitamin for a new, immune-modulating role in dermatology and oncology, offering a foundation for the development of next-generation skincare and therapeutic products that not only protect but actively enhance the skin’s immune function.
ADVANTAGES
ADVANTAGES
-
Enhances skin immunity by reprogramming dendritic cells to improve clearance of apoptotic cells and antigen presentation
-
Promotes faster and more effective wound healing, including in diabetic conditions
-
Reduces tumor growth and number by boosting anti-tumor immune responses in skin cancer models
-
Provides a novel, mechanism-based approach to skincare with immunomodulatory effects
-
Potentially improves patient responses to cancer therapies such as chemotherapy and CAR T-cell therapy
-
Utilizes a natural, water-soluble vitamin (Vitamin B1) with established safety profiles
-
Offers a foundation for developing topical treatments that protect against infections, wounds, and cancer
APPLICATIONS
-
Cosmeceuticals
-
Advanced wound healing creams
-
Topical anti-cancer therapies
-
Immunity-boosting skincare products
-
Adjunct therapy for skin infections
November 13, 2025
Proof of concept
Patent Pending
Licensing,Co-development
Jing Chen